Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

ASC30

AURORA-2

Ascletis Pharma (China) Co · Phase 3 · Recruiting · Enrollment 1560

NCT07743450

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
ASC30 Cohort 1n/rn/rn/rn/r
ASC30 Cohort 2n/rn/rn/rn/r
ASC30 Cohort 3n/rn/rn/rn/r
Placebo Cohort 4n/rn/rn/rn/r

Not shown

  • ASC30 Cohort 1: endpoint not reported
  • ASC30 Cohort 2: endpoint not reported
  • ASC30 Cohort 3: endpoint not reported
  • Placebo Cohort 4: endpoint not reported